Joshua Aiello serves as Executive at Orchestra BioMed Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Joshua Aiello has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2026 involved selling 241 shares valued at $1.0K.
Joshua Aiello currently holds 18,885 shares of Orchestra BioMed Holdings, Inc. (OBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Aiello has been a net neutral trader of OBIO stock. They have purchased $0 and sold $0 worth of shares.
Joshua Aiello's most recent insider trade was on Jan 2, 2026, when they sold 241 shares at $4.31 per share.
Get notified when new Form 4 filings are submitted
| $2.46 |
| Discretionary |
| Aug 7, 2025 | OBIO | $0 | Award | 15,000 | $N/A | Discretionary |
| Jul 20, 2023 | OBIO | $0 | Award | 5,000 | $N/A | Discretionary |